NM_001164458.2(ACTR3C):c.361C>T (p.Gln121Ter) AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
Mar 28, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000454558.4

Allele description [Variation Report for NM_001164458.2(ACTR3C):c.361C>T (p.Gln121Ter)]

NM_001164458.2(ACTR3C):c.361C>T (p.Gln121Ter)

Gene:
ACTR3C:actin related protein 3C [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_001164458.2(ACTR3C):c.361C>T (p.Gln121Ter)
HGVS:
  • NC_000007.14:g.150286477G>A
  • NM_001164458.2:c.361C>TMANE SELECT
  • NM_001164459.2:c.361C>T
  • NM_001351028.2:c.-181C>T
  • NP_001157930.1:p.Gln121Ter
  • NP_001157930.1:p.Gln121Ter
  • NP_001157931.1:p.Gln121Ter
  • NC_000007.13:g.149983566G>A
  • NM_001164458.1:c.361C>T
  • NR_147012.2:n.390C>T
  • NR_147013.2:n.327C>T
  • p.Gln121X
Protein change:
Q121*
Links:
dbSNP: rs78661149
NCBI 1000 Genomes Browser:
rs78661149
Molecular consequence:
  • NM_001351028.2:c.-181C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NR_147012.2:n.390C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147013.2:n.327C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001164458.2:c.361C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001164459.2:c.361C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000538224Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)		Benign
(Mar 28, 2016) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000538224.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC frequency

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024